Adherence Study in COPD Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

138

Participants

Timeline

Start Date

August 12, 2016

Primary Completion Date

October 31, 2017

Study Completion Date

October 31, 2017

Conditions
Chronic Obstructive Pulmonary Disease (COPD
Interventions
DEVICE

Arm 1: BreatheMate device with application

The service known as 'BreatheMate' is a patient support tool that monitors daily Symbicort inhaler use. The BreatheMate service includes a bluetooth monitoring device that is attached to subjects' Symbicort pMDI inhaler which automatically detects and logs their maintenance medication use. Subjects will receive audio-visual daily reminders (beeps and flashes) on the BreatheMate Bluetooth device. The bluetooth device transmits this data to a cellular phone that is provided to all subjects in the study. Subjects in the intervention group will also receive audio-visual alerts (beeps, flashes) from the bluetooth device to take their medication.

DEVICE

Arm 2: BreatheMate device without application

"The service known as 'BreatheMate' is a patient support tool that monitors daily Symbicort inhaler use. The BreatheMate service includes a bluetooth monitoring device that is attached to subjects' Symbicort pMDI inhaler which automatically detects and logs their maintenance medication use. The functionality of audio-visual daily reminders (beeps and flashes) is deactivated for this control group.~The BreatheMate service also includes a cellular phone that will display whether the Bluetooth monitoring device is paired and communicating with the cellular phone. The Bluetooth device will transmit data regarding medication usage to the cellular phone."

Trial Locations (8)

11229

Research Site, Brooklyn

19140

Research Site, Philadelphia

19335

Research Site, Downingtown

28207

Research Site, Charlotte

29303

Research Site, Spartanburg

33603

Research Site, Tampa

37765

Research Site, Clearwater

08053

Research Site, Marlton

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Quintiles, Inc.

INDUSTRY

lead

AstraZeneca

INDUSTRY